GLP-1 associated hair loss is unique in that the continued weight loss is a continued stressor,' said Jenni Holman, MD, FAAD, a diplomate of the American Academy of Dermatology
Medical records can help establish the date that you were prescribed the medication and any adverse reactions reported to your healthcare provider during its use
Retatrutide Recently, a 48-week, phase 2, dose-ranging trial evaluating a novel triple-hormone receptor agonist for obesity management was published
Early January 2026 According to Novo Nordisk, oral Wegovy is expected to launch in retail pharmacies and through select telehealth providers
How is BAC water volume determined for less common doses or non-standard vial sizes
They can improve weight loss and health and reduce mortality